HUM earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Hold, P/E 42.39. Updated 2026-07-23.
Humana (HUM) Research Hub
Humana (HUM) trades on NYSE, US in the Healthcare (Medical - Healthcare Plans) sector. As of 2026-09-11, shares last closed at 409.85 USD (+2.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 42.39, market cap 47.65B. This hub links to the full technical, earnings and options research available for HUM.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Plans) |
|---|---|
| Exchange | NYSE, US |
| Last close | 409.85 USD (+2.46%) |
| 52-week range | 353.06 USD – 428.88 USD |
| Trend regime | Range |
| 14-day RSI | 63.8 (Bullish) |
| Trailing P/E | 42.39 |
| Market cap | 47.65B |
| Dividend yield | 0.89% |
| Next earnings | 2026-07-29 |
Available research for HUM
Covered Call on HUM: how it works, illustrative setup around the real 409.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HUM: how it works, illustrative setup around the real 409.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HUM: how it works, illustrative setup around the real 409.85 USD price, max profit/loss, breakeven and when to use it. Educational.
HUM technical analysis: range, last 409.85 USD, RSI 63.8, 52w range 353.06 USD–428.88 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HUM in?
Humana (HUM) is classified under Healthcare (Medical - Healthcare Plans), listed on NYSE, US.
Is HUM in an uptrend or downtrend?
As of 2026-09-11, HUM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HUM's trailing P/E ratio?
HUM's trailing P/E is 42.39, with a market cap of 47.65B. See the earnings research page for full valuation detail.
When does HUM next report earnings?
HUM is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of 7.25 USD.